Basecare Medical (HK.2170) Receives NMPA Approval for Core Product Geri Medium, Unlocking New Opportunities in Assisted Reproduction
SUZHOU, China, Feb. 27, 2026 /PRNewswire/ -- Basecare Medical (02170.HK) has recently encountered a key catalyst——its Gems one-step embryo culture medium has officially obtained the China Class III Medical Device Registration Certificate (National Medical Products Administration Registration No. ...
The Rise of Advanced Maternal Age IVF: BaseCare Medical'-B(2170.HK) AI "Undisturbed Culture" Empowers Intelligent Assisted Reproduction
SUZHOU, China, Nov. 19, 2025 /PRNewswire/ -- Data from the keynote report at the 18th Annual Conference of the Chinese Society of Reproductive Medicine (CSRM2025), held fromNovember 12th to 15th, indicates that the average treatment age for women undergoing IVF inChina has risen to 33.6 years, h...
Basecare Medical (02170.HK) Gems Culture Medium Receives First Approval from NMPA, Advancing the Localization of Assisted Reproductive Fluids
SUZHOU, China, Aug. 26, 2025 /PRNewswire/ -- Recently, Suzhou Basecare Medical Co., Ltd. achieved a major breakthrough—its globally leading Gems culture medium (embryo handling solution VitBase) has officially received registration approval from the National Medical Products Administration (NMPA)...
BaseCare Medical (2170.HK) Unveils First Smart Home Sperm Analyzer, Pioneering "B+C" Full-Scenario Intelligent Expansion
SUZHOU, China, April 9, 2025 /PRNewswire/ -- BaseCare Medical, a trailblazer in reproductive health andChina's first publicly traded company in the assisted reproductive IVD sector, has secured regulatory approval for its portable home sperm quality analyzer (model: BKP200). As the nation's first...
Revenue Soars 44%, Basecare Medical (2170.HK) Advances Toward Global Intelligent Manufacturing
SUZHOU, China, March 31, 2025 /PRNewswire/ -- Amid frequent pro-fertility policy updates, Basecare Medical, a pioneer in the assisted reproductive IVD sector with full fertility health industry chain coverage, released its stellar 2024 performance report. The company achieved annual revenue of ne...
Industry Partnership | Basecare Medical Group (2170.HK) and Jinghua Medical Group Sign Strategic Cooperation Agreement
SUZHOU, China, Dec. 25, 2024 /PRNewswire/ -- On December 24, 2024, Basecare Medical Group (2170.HK) held a strategic cooperation signing ceremony with Jinghua Medical Group inShenyang. Basecare Medical possesses a comprehensive technological platform covering andrology, embryo culture, genetics, ...
The world's first live sperm analyzer has been launched! The Basecare Medical-B (2170. HK) intelligent sperm analyzer is expected to replace the traditional CASA diagnostic mode!
SUZHOU, China, Nov. 4, 2024 /PRNewswire/ -- According to the latest data from the Maternal and Child Health Department of the Chinese National Health Commission, there are currently 602 medical institutions inChina that have been approved to carry out human assisted reproductive technology, and t...
Basecare Medical (2170. HK) revenue growth exceeds 50% in 2024H1
SUZHOU, China , July 15, 2024 /PRNewswire/ -- Basecare Medical (2170. HK) released an unaudited interim performance forecast onJuly 12th, stating that the company's revenue for the first half of the year was approximatelyRMB 127 million to RMB 138 million, an increase of approximately 49% to 62% ...
Basecare Lists First Gene Sequencing Stock on Hong Kong Stock Exchange Ushering in Licensed Era of China's Third-Generation IVF Kit
HONG KONG, Feb. 8, 2021 /PRNewswire/ -- Basecare (Suzhou Basecare Medical Corporation Limited), an innovative assisted reproductive genetic testing enterprise, today officially listed on the main board of HKEX (HKG: 2170). Approximately 66.667 million shares were issued and total funds raised was...
Assisted Reproduction Unicorn Basecare Medical to IPO in Hong Kong
SUZHOU, China, Feb. 1, 2021 /PRNewswire/ -- Suzhou Basecare Medical Co., Ltd. (Basecare Medical) — set to list on the Hong Kong Stock Exchange onFebruary 8th , 2021— is the newest unicorn in the field of assisted reproduction. The planned IPO comes after a very successful and profitable 2020, favo...
